Q2 2026 results exceeded expectations, with adjusted EPS of $2.51 and strong segment performance driving a raised full-year EPS outlook above $4.80. Medicaid, Medicare, and Marketplace all showed margin improvement, supported by operational efficiencies, AI investments, and favorable risk adjustment outcomes.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.